{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:28:32Z","timestamp":1772839712513,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to identify the clinical characteristics and longitudinal changes in exudative pachychoroid neovasculopathy (PNV) and non-exudative PNV. This retrospective cohort study involved 81 eyes of PNV diagnosed by multimodal imaging including optical coherence tomography angiography. At baseline, they were divided into exudative PNV group and non-exudative PNV group depending on the presence of subretinal fluid. The clinical features of both groups and the longitudinal changes were investigated and compared. There were 55 eyes with non-exudative PNV and 26 eyes with exudative PNV. Individuals with non-exudative PNV were older, more frequently asymptomatic and had a higher prevalence of polypoidal choroidal vasculopathy in the opposite eye (all <jats:italic>P<\/jats:italic>\u2019s\u2009&lt;\u20090.05). Whereas individuals with exudative PNV showed thicker choroid and more frequent history of central serous chorioretinopathy (all <jats:italic>P<\/jats:italic>\u2019s\u2009&lt;\u20090.001). During about 12\u00a0months of longitudinal observation, the transformation into polypoidal choroidal vasculopathy was noted in 4 eyes of non-exudative PNV group, whereas in none of the exudative PNV group. Exudative PNV and non-exudative PNV seem to be separate entities with different epidemiological parameters. Non-exudative PNV, which is frequently found without symptoms at an older age, is suspected to be the significant precursor lesion of polypoidal choroidal vasculopathy. In contrast, exudative PNV may share the same pathophysiology as central serous chorioretinopathy.<\/jats:p>","DOI":"10.1038\/s41598-021-83650-x","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:14:59Z","timestamp":1613812499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The implications of subretinal fluid in pachychoroid neovasculopathy"],"prefix":"10.1038","volume":"11","author":[{"given":"Geun Woo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Cheol","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Woong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Jun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"83650_CR1","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","volume":"33","author":"DJ Warrow","year":"2013","unstructured":"Warrow, D. J., Hoang, Q. V. & Freund, K. B. Pachychoroid pigment epitheliopathy. Retina (Philadelphia, Pa.) 33, 1659\u20131672 (2013).","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"83650_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","volume":"35","author":"CE Pang","year":"2015","unstructured":"Pang, C. E. & Freund, K. B. Pachychoroid neovasculopathy. Retina (Philadelphia, Pa.) 35, 1\u20139 (2015).","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"83650_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung, C. M. G. et al. Pachychoroid disease. Eye (London, England) 33, 14\u201333 (2019).","journal-title":"Eye (London, England)"},{"key":"83650_CR4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","volume":"32","author":"AT Fung","year":"2012","unstructured":"Fung, A. T., Yannuzzi, L. A. & Freund, K. B. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina (Philadelphia, Pa.) 32, 1829\u20131837 (2012).","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"83650_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/IAE.0b013e31823beb14","volume":"32","author":"S Khan","year":"2012","unstructured":"Khan, S., Engelbert, M., Imamura, Y. & Freund, K. B. Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina (Philadelphia, Pa.) 32, 1057\u20131068 (2012).","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"83650_CR6","doi-asserted-by":"publisher","first-page":"19240","DOI":"10.1038\/s41598-019-55871-8","volume":"9","author":"K Bae","year":"2019","unstructured":"Bae, K., Kim, H. J., Shin, Y. K. & Kang, S. W. Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography. Sci. Rep. 9, 19240 (2019).","journal-title":"Sci. Rep."},{"key":"83650_CR7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/IAE.0000000000002108","volume":"39","author":"S Hwang","year":"2019","unstructured":"Hwang, S., Kang, S. W., Kim, S. J., Jang, J. W. & Kim, K. T. Photodynamic therapy for symptomatic subfoveal retinal pigment epithelial detachment in central serous chorioretinopathy: Outcomes and Prognostic Factors. Retina 39, 1117\u20131124 (2019).","journal-title":"Retina"},{"key":"83650_CR8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00417-017-3793-8","volume":"255","author":"S Demirel","year":"2017","unstructured":"Demirel, S., Yanik, O., Nalci, H., Batioglu, F. & Ozmert, E. The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 255, 2317\u20132324 (2017).","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"83650_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00417-018-4201-8","volume":"257","author":"K Bae","year":"2019","unstructured":"Bae, K. et al. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 257, 279\u2013288 (2019).","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"83650_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/IAE.0000000000000809","volume":"36","author":"JH Lee","year":"2016","unstructured":"Lee, J. H. & Lee, W. K. One-year results of adjunctive photodynamic therapy for type 1 neovascularization associated with thickened choroid. Retina (Philadelphia, Pa.) 36, 889\u2013895 (2016).","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"83650_CR11","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41598-019-38504-y","volume":"9","author":"BJ Jung","year":"2019","unstructured":"Jung, B. J. et al. Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci. Rep. 9, 2055 (2019).","journal-title":"Sci. Rep."},{"key":"83650_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1167\/iovs.17-22144","volume":"59","author":"N Padron-Perez","year":"2018","unstructured":"Padron-Perez, N. et al. Changes in choroidal thickness after intravitreal injection of anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Invest. Ophthalmol. Vis. Sci. 59, 1119\u20131124 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"83650_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich, A. et al. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog. Retin. Eye Res. 48, 82\u2013118 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"83650_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.oret.2020.03.024","volume":"4","author":"H Matsumoto","year":"2020","unstructured":"Matsumoto, H. et al. Vortex vein anastomosis at the watershed in pachychoroid spectrum diseases. Ophthalmol. Retina 4, 938\u2013945 (2020).","journal-title":"Ophthalmol. Retina"},{"key":"83650_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","volume":"160","author":"KK Dansingani","year":"2015","unstructured":"Dansingani, K. K., Balaratnasingam, C., Klufas, M. A., Sarraf, D. & Freund, K. B. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am. J. Ophthalmol. 160, 1243-1254.e1242 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"83650_CR16","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1167\/iovs.13-11665","volume":"54","author":"G Querques","year":"2013","unstructured":"Querques, G. et al. Functional characterization and multimodal imaging of treatment-naive \u201cquiescent\u201d choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 54, 6886\u20136892 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"83650_CR17","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1167\/iovs.16-21167","volume":"58","author":"Y Yanagi","year":"2017","unstructured":"Yanagi, Y. et al. Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest. Ophthalmol. Vis. Sci. 58, 3488\u20133495 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"83650_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","volume":"121","author":"SH Bae","year":"2014","unstructured":"Bae, S. H. et al. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial. Ophthalmology 121, 558\u2013565 (2014).","journal-title":"Ophthalmology"},{"key":"83650_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1167\/iovs.16-20967","volume":"58","author":"M Hata","year":"2017","unstructured":"Hata, M. et al. Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 58, 292\u2013298 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"83650_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00417-020-04623-w","volume":"258","author":"B Schworm","year":"2020","unstructured":"Schworm, B. et al. Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 258, 1013\u20131021 (2020).","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol. = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"83650_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ajo.2013.06.013","volume":"156","author":"JH Kim","year":"2013","unstructured":"Kim, J. H., Kang, S. W., Kim, T. H., Kim, S. J. & Ahn, J. Structure of polypoidal choroidal vasculopathy studied by colocalization between tomographic and angiographic lesions. Am. J. Ophthalmol. 156, 974-980.e972 (2013).","journal-title":"Am. J. Ophthalmol."},{"key":"83650_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/bjophthalmol-2012-301644","volume":"96","author":"YT Kim","year":"2012","unstructured":"Kim, Y. T., Kang, S. W., Chung, S. E., Kong, M. G. & Kim, J. H. Development of polypoidal choroidal vasculopathy in unaffected fellow eyes. Br. J. Ophthalmol. 96, 1217\u20131221 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"83650_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/bjo.2008.145862","volume":"93","author":"SW Kang","year":"2009","unstructured":"Kang, S. W., Chung, S. E., Shin, W. J. & Lee, J. H. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography. Br. J. Ophthalmol. 93, 759\u2013764 (2009).","journal-title":"Br. J. Ophthalmol."},{"key":"83650_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ajo.2014.12.012","volume":"159","author":"T Alasil","year":"2015","unstructured":"Alasil, T. et al. En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography. Am. J. Ophthalmol. 159, 634\u2013643 (2015).","journal-title":"Am. J. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83650-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:45:43Z","timestamp":1670039143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83650-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83650"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83650-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4066"}}